M
Marco Valgimigli
Researcher at University of Bern
Publications - 772
Citations - 91095
Marco Valgimigli is an academic researcher from University of Bern. The author has contributed to research in topics: Percutaneous coronary intervention & Myocardial infarction. The author has an hindex of 105, co-authored 696 publications receiving 69184 citations. Previous affiliations of Marco Valgimigli include University of Düsseldorf & Erasmus University Medical Center.
Papers
More filters
Journal ArticleDOI
Rates and predictors of hospital readmission after transcatheter aortic valve implantation.
Anna Franzone,Thomas Pilgrim,Nicolas Arnold,Dik Heg,Bettina Langhammer,Raffaele Piccolo,Eva Roost,Fabien Praz,Lorenz Räber,Marco Valgimigli,Peter Wenaweser,Peter Jüni,Thierry Carrel,Stephan Windecker,Stefan Stortecky +14 more
TL;DR: Hospital readmission was observed in one out of four patients during the first year after TAVI and was associated with a significant increase in mortality.
Journal ArticleDOI
One year clinical follow up of paclitaxel eluting stents for acute myocardial infarction compared with sirolimus eluting stents
Sjoerd H. Hofma,Andrew T.L. Ong,Jiro Aoki,C A G Van Mieghem,G.A. Rodriguez Granillo,Marco Valgimigli,Eveline Regar,P. de Jaegere,Eugene P. McFadden,G. Sianos,W.J. van der Giessen,P. J. De Feyter,R.T. van Domburg,P. W. Serruys +13 more
TL;DR: No significant differences were seen in MACE-free survival at one year between SES and PES for the treatment of acute myocardial infarction with very low rates of reintervention for restenosis.
Journal ArticleDOI
Dual antiplatelet therapy duration after coronary stenting in clinical practice: results of an EAPCI survey.
Marco Valgimigli,Francesco Costa,Robert A. Byrne,Michael Haude,Andreas Baumbach,Stephan Windecker +5 more
TL;DR: This EAPCI survey highlights considerable uncertainty within the medical community with regard to the optimal duration of DAPT after coronary stenting in the light of recent reported trial results.
Journal ArticleDOI
Clinical effectiveness of bare-metal stenting compared with balloon angioplasty in total coronary occlusions: Insights from a systematic overview of randomized trials in light of the drug-eluting stent era
Pierfrancesco Agostoni,Pierfrancesco Agostoni,Marco Valgimigli,Giuseppe Biondi-Zoccai,Antonio Abbate,Hector Garcia Garcia,Maurizio Anselmi,Marco Turri,Eugene P. McFadden,Corrado Vassanelli,Patrick W. Serruys,Antonio Colombo +11 more
TL;DR: In total coronary occlusions, stenting yields an important benefit over balloon angioplasty in reduction of MACE, repeated revascularizations, and angiographic restenosis and reocclusion, however, these events remain frequent.
Journal ArticleDOI
The 5-year clinical outcomes after a randomized comparison of sirolimus-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction
Matteo Tebaldi,Chiara Arcozzi,Gianluca Campo,Gianfranco Percoco,Roberto Ferrari,Marco Valgimigli,Strategy Investigators +6 more
TL;DR: To the Editor: Because patients with acute ST-segment elevation myocardial infarction (STEMI) were excluded from early randomized trials, only relatively short-term data from large multicenter studies comparing drug-eluting stent (DES) with bare-metal stents (BMS) are currently available.